Skip to content

Safety and accuracy follow different scaling laws in clinical large language models

Lena MüllerLena Müller
|
|15 Min Read
Safety and accuracy follow different scaling laws in clinical large language models
Shawn Day|Unsplash

Photo by Shawn Day on Unsplash

Section 1 – What happened? A groundbreaking study has revealed that the relationship between the accuracy and safety of clinical large language models…

Reporting by Sebastian Wind, SwissFinanceAI Redaktion

ai-toolsnewsresearch

Safety and accuracy follow different scaling laws in clinical large language models

Safety and accuracy follow different scaling laws in clinical large language models

Section 1 – What happened?

A groundbreaking study has revealed that the relationship between the accuracy and safety of clinical large language models (LLMs) is more complex than previously thought. Researchers from various institutions have developed a framework called SaFE-Scale to measure the impact of different scaling factors on the safety of clinical LLMs. To test this framework, they created a benchmark called RadSaFE-200, consisting of 200 multiple-choice questions related to radiology, which were designed to evaluate the models' ability to provide safe and accurate responses. The study involved evaluating 34 locally deployed LLMs across six different deployment conditions, including closed-book prompting, clean evidence, conflict evidence, standard RAG, agentic RAG, and max-context prompting.

Section 2 – Background & Context

Clinical LLMs are increasingly being used in healthcare to assist with diagnosis, treatment, and patient care. However, the safety of these models is a major concern, as a single mistake can have serious consequences. Traditionally, the accuracy of LLMs has been measured using benchmark tests, but this approach assumes that higher accuracy implies safer behavior. However, this assumption is incomplete, as a few confident, high-risk, or evidence-contradicting errors can have a disproportionate impact on patient outcomes. The development of SaFE-Scale and RadSaFE-200 aims to provide a more comprehensive understanding of the relationship between accuracy and safety in clinical LLMs.

Section 3 – Impact on Swiss SMEs & Finance

While the study's findings may not have a direct impact on Swiss SMEs or finance, they do have broader implications for the development and deployment of AI-powered healthcare solutions. The study highlights the need for a more nuanced approach to evaluating the safety of clinical LLMs, one that takes into account the specific deployment conditions and the potential risks associated with each. This knowledge can inform the development of more robust and safe AI-powered healthcare solutions, which can benefit patients and healthcare providers worldwide.

Section 4 – What to Watch

The study's findings suggest that the safety of clinical LLMs is not a passive consequence of scaling, but rather a deployment property shaped by evidence quality, retrieval design, context construction, and collective failure behavior. As the use of clinical LLMs continues to grow, it will be essential to monitor the development of new frameworks and benchmarks that can help ensure the safe and effective deployment of these models. Readers should keep an eye on the further development of SaFE-Scale and RadSaFE-200, as well as the emergence of new benchmarks and frameworks that can help address the complex relationship between accuracy and safety in clinical LLMs.

Source

Original Article: Safety and accuracy follow different scaling laws in clinical large language models

Published: May 5, 2026

Author: Sebastian Wind


Disclaimer: This article is for informational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions.

Disclaimer

This article is for informational purposes only and does not constitute financial, legal, or tax advice. SwissFinanceAI is not a licensed financial services provider. Always consult a qualified professional before making financial decisions.

This content was created with AI assistance. All cited sources have been verified. We comply with EU AI Act (Article 50) disclosure requirements.

ShareLinkedInXWhatsApp
Lena Müller
Lena MüllerSwiss Markets & Macroeconomics

Swiss Markets & Macroeconomics

Lena Müller analyses Swiss and European financial markets daily — from SMI movements to SNB decisions and geopolitical risks. Her focus is data-driven analysis delivering directly actionable insights for Swiss SME finance professionals.

AI editorial agent specialising in Swiss financial market analysis. Generated by the SwissFinanceAI editorial system.

Newsletter

Swiss AI & Finance — straight to your inbox

Weekly digest of the most important news for Swiss finance professionals. No spam.

By subscribing you agree to our Privacy Policy. Unsubscribe anytime.

References

  1. [1]NewsCredibility: 9/10
    ArXiv AI Papers. "Safety and accuracy follow different scaling laws in clinical large language models." May 5, 2026.

Transparency Notice: This article may contain AI-assisted content. All citations link to verified sources. We comply with EU AI Act (Article 50) and FTC guidelines for transparent AI disclosure.

Original Source

blog.relatedArticles

Newsletter

Weekly Swiss AI & Finance digest

SwissFinanceAI

AI-powered finance news and automation for Swiss businesses.

Hinweis · Notice: All articles reflect personal opinions and experience as editorial value-judgments. They do not replace individual financial, legal, or tax advice. SwissFinanceAI is not supervised by FINMA and is not a registered financial service provider (FIDLEG SR 950.1). Corrections: info@swissfinanceai.ch.

© 2026 SwissFinanceAI. All rights reserved.

Website developed by Otterino